Clustering data with hclust algorithm for Eleostearic acid effects on TAGs and oxLipids (Study ST001451)

Reversed phase POSITIVE ION MODE (Analysis AN002426)
MetaboliteStructureF1F2F3F4
TG(50:7)ME3383223.660.030.280.03
TG(50:3)ME3383260.740.800.951.51
TG(52:3)ME3383370.710.870.991.43
TG(50:2)ME3383270.600.870.981.54
TG(48:1)ME3383200.570.960.931.55
TG(44:0)ME3383180.650.980.851.52
TG(52:2)ME3383380.630.970.921.48
TG(56:2)ME3383770.651.150.831.37
TG(46:0)ME3383190.631.080.851.44
TG(52:1)ME3383410.691.070.801.44
TG(58:3)ME3383910.801.070.821.31
TG(56:0)ME3383800.851.060.761.33
TG(58:0)ME3383960.851.040.781.33
TG(48:0)ME3383210.811.050.921.22
TG(54:2)ME3383580.761.080.901.26
TG(54:3)ME3383550.760.940.961.34
TG(56:3)ME3383760.800.970.941.28
TG(50:0)ME3383290.701.040.961.30
TG(50:1)ME3383280.680.990.951.39
TG(50:6)+4OME3383560.831.270.960.94
TG(50:4)+4OME3383610.891.300.801.01
TG(54:10)+2OME3383690.951.300.780.97
TG(50:6)+2OME3383350.971.160.851.01
TG(62:4)ME3384210.921.220.781.09
TG(58:2)ME3383920.711.320.511.45
TG(54:1)ME3383600.761.310.781.16
TG(62:2)ME3384230.711.380.651.25
TG(62:3)ME3384220.661.320.681.34
TG(58:1)ME3383940.651.350.631.38
TG(60:1)ME3384100.661.390.641.31
TG(60:2)ME3384080.661.380.641.33
TG(52:0)ME3383430.731.230.761.28
TG(54:0)ME3383630.711.240.731.32
TG(52:7)+4OME3383750.801.300.651.25
TG(56:1)ME3383780.711.290.671.33
TG(60:3)ME3384070.751.280.671.29
TG(52:9)+1OME3383390.770.701.710.82
TG(64:15)ME3384241.700.671.160.46
TG(54:11)+2OME3383671.301.290.810.60
TG(54:10)+1OME3383571.040.681.131.16
TG(56:4)ME3383740.950.811.151.10
TG(42:0)ME3383170.710.731.231.33
TG(50:2)+2OME3383420.690.871.121.32
TG(54:4)ME3383541.160.601.490.75
TG(56:7)ME3383711.100.661.470.77
TG(56:5)ME3383731.130.741.310.82
TG(56:6)ME3383721.130.711.290.87
TG(54:8)+1OME3383621.370.701.170.77
TG(60:5)ME3384051.190.761.310.73
TG(60:11)ME3383991.280.741.270.71
TG(60:9)ME3384011.270.781.240.71
TG(50:4)+3OME3383481.221.110.860.81
TG(56:8)+1OME3383791.071.051.000.88
TG(62:6)ME3384191.061.101.000.84
TG(62:11)ME3384141.121.070.880.92
TG(60:8)ME3384021.160.980.900.95
TG(62:8)ME3384171.151.020.920.90
TG(50:10)+4OME3383510.961.000.991.04
TG(58:6)ME3383881.110.921.040.93
TG(60:4)ME3384061.120.961.070.84
TG(60:6)ME3384041.120.951.070.87
TG(58:8)ME3383861.080.881.041.01
TG(58:7)ME3383871.120.821.120.93
TG(58:4)ME3383901.050.831.131.00
TG(58:5)ME3383891.040.821.170.97
TG(60:10)ME3384001.490.741.110.66
TG(62:13)ME3384121.450.790.990.77
TG(62:5)ME3384201.150.901.210.74
TG(62:7)ME3384181.180.961.110.75
TG(60:7)ME3384031.270.831.100.79
TG(62:9)ME3384161.360.881.040.71
TG(62:10)ME3384151.330.940.970.76
TG(62:12)ME3384131.310.891.010.78
TG(50:3)+2OME3383402.540.350.770.35
TG(50:5)+4OME3383591.900.820.470.81
TG(58:11)ME3383830.350.113.430.11
TG(56:11)ME3383651.530.012.450.01
TG(52:6)ME3383331.490.062.390.06
TG(56:10)ME3383661.510.042.420.03
TG(54:7)ME3383501.580.102.200.12
TG(54:8)ME3383491.600.062.280.07
TG(58:13)ME3383811.700.062.160.07
TG(56:12)ME3383641.710.012.270.01
TG(52:8)ME3383311.750.022.210.02
TG(58:12)ME3383821.740.022.220.02
TG(50:6)ME3383231.220.022.750.02
TG(54:10)ME3383461.340.012.630.02
TG(54:9)ME3383471.320.012.660.01
TG(52:7)ME3383321.290.022.670.03
TG(52:9)ME3383301.300.002.690.00
TG(50:4)ME3383251.310.122.350.23
TG(52:5)ME3383341.290.192.300.22
TG(50:5)ME3383241.260.132.440.17
TG(56:9)ME3383681.270.102.550.09
TG(60:15)ME3383932.310.071.560.06
TG(60:14)ME3383952.120.051.790.04
TG(62:15)ME3384092.060.051.830.06
TG(54:6)ME3383521.390.242.100.28
TG(52:4)ME3383361.240.252.100.40
TG(54:5)ME3383531.340.291.960.42
TG(54:12)ME3383441.530.451.820.20
TG(56:8)ME3383701.510.371.710.41
TG(58:9)ME3383851.580.361.720.34
TG(54:11)ME3383451.630.182.010.18
TG(58:10)ME3383841.860.171.820.15
TG(62:14)ME3384111.850.241.700.21
TG(60:12)ME3383981.770.251.730.24
TG(60:13)ME3383971.790.221.790.21

Factors:

F1siRNA:ACSL1 | Treatment (8hrs):eleostearic acid (25µM)
F2siRNA:ACSL1 | Treatment (8hrs):Vehicle (methanol)
F3siRNA:Control | Treatment (8hrs):eleostearic acid (25µM)
F4siRNA:Control | Treatment (8hrs):Vehicle (methanol)
Data matrix
  logo